BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 33810032)

  • 1. Specific Patterns of Blood ILCs in Metastatic Melanoma Patients and Their Modulations in Response to Immunotherapy.
    Rethacker L; Roelens M; Bejar C; Maubec E; Moins-Teisserenc H; Caignard A
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33810032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD56
    Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
    Front Immunol; 2019; 10():14. PubMed ID: 30761123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Human ILCs and Impact of Unconventional Cytotoxic Subsets in the Pathophysiology of Inflammatory Diseases and Cancer.
    Calvi M; Di Vito C; Frigo A; Trabanelli S; Jandus C; Mavilio D
    Front Immunol; 2022; 13():914266. PubMed ID: 35720280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low baseline levels of NK cells may predict a positive response to ipilimumab in melanoma therapy.
    Tietze JK; Angelova D; Heppt MV; Ruzicka T; Berking C
    Exp Dermatol; 2017 Jul; 26(7):622-629. PubMed ID: 27892653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate Lymphoid Cells: Expression of PD-1 and Other Checkpoints in Normal and Pathological Conditions.
    Mariotti FR; Quatrini L; Munari E; Vacca P; Moretta L
    Front Immunol; 2019; 10():910. PubMed ID: 31105707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK cells and ILCs in tumor immunotherapy.
    Sivori S; Pende D; Quatrini L; Pietra G; Della Chiesa M; Vacca P; Tumino N; Moretta F; Mingari MC; Locatelli F; Moretta L
    Mol Aspects Med; 2021 Aug; 80():100870. PubMed ID: 32800530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helper Innate Lymphoid Cells-Unappreciated Players in Melanoma Therapy.
    Garofalo C; Cerantonio A; Muscoli C; Mollace V; Viglietto G; De Marco C; Cristiani CM
    Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Frequencies and Functions of Innate Lymphoid Cells in Melanoma Patients Are Modulated by Immune Checkpoints Inhibitors.
    Cristiani CM; Capone M; Garofalo C; Madonna G; Mallardo D; Tuffanelli M; Vanella V; Greco M; Foti DP; Viglietto G; Ascierto PA; Spits H; Carbone E
    Front Immunol; 2022; 13():811131. PubMed ID: 35173725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral Innate Lymphoid Cells Are Increased in First Line Metastatic Colorectal Carcinoma Patients: A Negative Correlation With Th1 Immune Responses.
    Loyon R; Jary M; Salomé B; Gomez-Cadena A; Galaine J; Kroemer M; Romero P; Trabanelli S; Adotévi O; Borg C; Jandus C
    Front Immunol; 2019; 10():2121. PubMed ID: 31555301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of several activating and inhibitory receptors on CD3(-)CD56(+) NK cells in regional lymph nodes of melanoma patients.
    Vuletić A; Jurišić V; Jovanić I; Milovanović Z; Nikolić S; Konjević G
    J Surg Res; 2013 Aug; 183(2):860-8. PubMed ID: 23522458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells.
    Munari E; Quatrini L; Ciancaglini C; Eccher A; Bogina G; Moretta L; Mariotti FR
    Semin Immunol; 2022 Nov; 61-64():101660. PubMed ID: 36370672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML.
    Salomé B; Gomez-Cadena A; Loyon R; Suffiotti M; Salvestrini V; Wyss T; Vanoni G; Ruan DF; Rossi M; Tozzo A; Tentorio P; Bruni E; Riether C; Jacobsen EM; Jandus P; Conrad C; Hoenig M; Schulz A; Michaud K; Della Porta MG; Salvatore S; Ho PC; Gfeller D; Ochsenbein A; Mavilio D; Curti A; Marcenaro E; Steinle A; Horowitz A; Romero P; Trabanelli S; Jandus C
    Blood Adv; 2019 Nov; 3(22):3674-3687. PubMed ID: 31765481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate lymphoid cells: NK and cytotoxic ILC3 subsets infiltrate metastatic breast cancer lymph nodes.
    Rethacker L; Boy M; Bisio V; Roussin F; Denizeau J; Vincent-Salomon A; Borcoman E; Sedlik C; Piaggio E; Toubert A; Dulphy N; Caignard A
    Oncoimmunology; 2022; 11(1):2057396. PubMed ID: 35371620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific phenotype and function of CD56-expressing innate immune cell subsets in human thymus.
    Gerstner S; Köhler W; Heidkamp G; Purbojo A; Uchida S; Ekici AB; Heger L; Luetke-Eversloh M; Schubert R; Bader P; Klingebiel T; Koehl U; Mackensen A; Romagnani C; Cesnjevar R; Dudziak D; Ullrich E
    J Leukoc Biol; 2016 Dec; 100(6):1297-1310. PubMed ID: 27354408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer.
    Maas RJ; Hoogstad-van Evert JS; Van der Meer JM; Mekers V; Rezaeifard S; Korman AJ; de Jonge PK; Cany J; Woestenenk R; Schaap NP; Massuger LF; Jansen JH; Hobo W; Dolstra H
    Oncoimmunology; 2020 Nov; 9(1):1843247. PubMed ID: 33224630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients.
    Konjević G; Mirjačić Martinović K; Vuletić A; Babović N
    Melanoma Res; 2010 Dec; 20(6):459-67. PubMed ID: 20938360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helper Innate Lymphoid Cells in Human Tumors: A Double-Edged Sword?
    Tumino N; Vacca P; Quatrini L; Munari E; Moretta F; Pelosi A; Mariotti FR; Moretta L
    Front Immunol; 2019; 10():3140. PubMed ID: 32063901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients.
    Mirjačić Martinović KM; Babović NLj; Džodić RR; Jurišić VB; Tanić NT; Konjević GM
    Melanoma Res; 2014 Aug; 24(4):295-304. PubMed ID: 24769842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New miRNA Signature Heralds Human NK Cell Subsets at Different Maturation Steps: Involvement of miR-146a-5p in the Regulation of KIR Expression.
    Pesce S; Squillario M; Greppi M; Loiacono F; Moretta L; Moretta A; Sivori S; Castagnola P; Barla A; Candiani S; Marcenaro E
    Front Immunol; 2018; 9():2360. PubMed ID: 30374356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A temporal developmental map separates human NK cells from noncytotoxic ILCs through clonal and single-cell analysis.
    Vo DN; Yuan O; Kanaya M; Telliam-Dushime G; Li H; Kotova O; Caglar E; Honnens de Lichtenberg K; Rahman SH; Soneji S; Scheding S; Bryder D; Malmberg KJ; Sitnicka E
    Blood Adv; 2024 Jun; 8(11):2933-2951. PubMed ID: 38484189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.